Safety Assessment of SAR341402 and NovoLog ® Used in Continuous Subcutaneous Insulin Infusion for Type 1 Diabetes Mellitus Patients

Condition:   Type 1 Diabetes Mellitus Interventions:   Drug: Insulin aspart SAR341402;   Drug: Insulin aspart Sponsor:   Sanofi Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials